Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomyopathy, Hypertrophic | 11 | 2022 | 116 | 3.460 |
Why?
|
| Ablation Techniques | 3 | 2022 | 33 | 1.770 |
Why?
|
| Catheter Ablation | 6 | 2021 | 229 | 1.300 |
Why?
|
| Cardiac Catheterization | 5 | 2022 | 419 | 0.900 |
Why?
|
| Chest Pain | 1 | 2019 | 151 | 0.650 |
Why?
|
| Heart-Assist Devices | 1 | 2020 | 221 | 0.620 |
Why?
|
| Heart Transplantation | 1 | 2020 | 328 | 0.610 |
Why?
|
| Tachycardia, Sinus | 1 | 2017 | 4 | 0.610 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 450 | 0.600 |
Why?
|
| Urinary Tract Infections | 1 | 2017 | 71 | 0.570 |
Why?
|
| Ethanol | 7 | 2021 | 892 | 0.570 |
Why?
|
| Catheterization | 2 | 2008 | 209 | 0.510 |
Why?
|
| Heart Septum | 6 | 2021 | 84 | 0.500 |
Why?
|
| Pulmonary Embolism | 1 | 2017 | 253 | 0.500 |
Why?
|
| Heart Failure | 2 | 2020 | 1179 | 0.490 |
Why?
|
| Pulmonary Artery | 3 | 2020 | 323 | 0.430 |
Why?
|
| Aged | 13 | 2021 | 14842 | 0.370 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2020 | 102 | 0.340 |
Why?
|
| Treatment Outcome | 10 | 2022 | 7028 | 0.340 |
Why?
|
| Blood Flow Velocity | 2 | 2013 | 172 | 0.320 |
Why?
|
| Hypertension, Pulmonary | 2 | 2020 | 232 | 0.300 |
Why?
|
| Middle Aged | 14 | 2021 | 21119 | 0.250 |
Why?
|
| Humans | 22 | 2022 | 68525 | 0.240 |
Why?
|
| Coronary Angiography | 5 | 2019 | 866 | 0.240 |
Why?
|
| Male | 15 | 2020 | 37281 | 0.220 |
Why?
|
| Coronary Circulation | 2 | 2013 | 136 | 0.220 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2002 | 16 | 0.210 |
Why?
|
| Radial Artery | 1 | 2022 | 43 | 0.210 |
Why?
|
| Femoral Artery | 1 | 2022 | 139 | 0.210 |
Why?
|
| Aneurysm | 1 | 2002 | 53 | 0.210 |
Why?
|
| Retrospective Studies | 4 | 2022 | 7264 | 0.200 |
Why?
|
| Mitral Valve | 1 | 2002 | 166 | 0.190 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2020 | 20 | 0.190 |
Why?
|
| Heart Valve Prosthesis | 1 | 2002 | 222 | 0.190 |
Why?
|
| Coronary Vessels | 2 | 2013 | 313 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor D | 1 | 2019 | 10 | 0.180 |
Why?
|
| Coronary Artery Disease | 2 | 2018 | 696 | 0.180 |
Why?
|
| Prospective Studies | 6 | 2020 | 3702 | 0.160 |
Why?
|
| Adult | 9 | 2021 | 21375 | 0.160 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2018 | 100 | 0.150 |
Why?
|
| Intestinal Obstruction | 1 | 2017 | 36 | 0.150 |
Why?
|
| Echocardiography, Doppler | 3 | 2008 | 87 | 0.150 |
Why?
|
| Female | 13 | 2021 | 38015 | 0.150 |
Why?
|
| Fatal Outcome | 1 | 2017 | 164 | 0.150 |
Why?
|
| Electrocardiography | 1 | 2019 | 601 | 0.150 |
Why?
|
| Exercise Tolerance | 2 | 2008 | 75 | 0.140 |
Why?
|
| Defibrillators, Implantable | 2 | 2010 | 329 | 0.140 |
Why?
|
| Coronary Stenosis | 1 | 2018 | 246 | 0.140 |
Why?
|
| Ventricular Function, Left | 3 | 2008 | 481 | 0.130 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2010 | 277 | 0.120 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 424 | 0.120 |
Why?
|
| Follow-Up Studies | 4 | 2008 | 3256 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 2323 | 0.110 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2012 | 45 | 0.110 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 1465 | 0.110 |
Why?
|
| Patient Selection | 2 | 2013 | 592 | 0.100 |
Why?
|
| Sensitivity and Specificity | 4 | 2019 | 1753 | 0.100 |
Why?
|
| Differential Threshold | 1 | 2010 | 27 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2008 | 536 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2222 | 0.090 |
Why?
|
| Stroke Volume | 3 | 2019 | 586 | 0.090 |
Why?
|
| Electric Countershock | 1 | 2010 | 130 | 0.090 |
Why?
|
| Injections, Intra-Arterial | 1 | 2008 | 30 | 0.080 |
Why?
|
| Decision Making | 1 | 2012 | 410 | 0.080 |
Why?
|
| Heart Block | 1 | 2008 | 49 | 0.080 |
Why?
|
| Coronary Aneurysm | 1 | 2008 | 19 | 0.080 |
Why?
|
| Texas | 1 | 2008 | 92 | 0.080 |
Why?
|
| Angina Pectoris | 1 | 2008 | 61 | 0.080 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2008 | 99 | 0.080 |
Why?
|
| Dyspnea | 1 | 2008 | 87 | 0.080 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2008 | 174 | 0.080 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2008 | 141 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2013 | 1447 | 0.070 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2008 | 164 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2021 | 2004 | 0.070 |
Why?
|
| Time Factors | 3 | 2013 | 4655 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1851 | 0.060 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2002 | 100 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 2077 | 0.060 |
Why?
|
| Dilatation, Pathologic | 1 | 2002 | 58 | 0.050 |
Why?
|
| South Carolina | 1 | 2008 | 2750 | 0.050 |
Why?
|
| Prosthesis Failure | 1 | 2002 | 130 | 0.050 |
Why?
|
| Heart Valve Diseases | 1 | 2002 | 123 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 4843 | 0.050 |
Why?
|
| Cardiac Conduction System Disease | 1 | 2020 | 11 | 0.050 |
Why?
|
| Bundle-Branch Block | 1 | 2021 | 50 | 0.050 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2020 | 61 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2002 | 344 | 0.040 |
Why?
|
| Lymphangiogenesis | 1 | 2019 | 10 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 1046 | 0.040 |
Why?
|
| Echocardiography | 1 | 2002 | 515 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2019 | 169 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2019 | 705 | 0.040 |
Why?
|
| Algorithms | 1 | 2002 | 1194 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1037 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 1329 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 2093 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1593 | 0.030 |
Why?
|
| Adenosine | 1 | 2013 | 165 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2013 | 384 | 0.020 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2012 | 137 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2012 | 275 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2013 | 506 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1139 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2008 | 25 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 1425 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 244 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 1860 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2008 | 115 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 951 | 0.020 |
Why?
|
| Survival Rate | 1 | 2008 | 1055 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 5719 | 0.010 |
Why?
|
| Diastole | 1 | 2003 | 161 | 0.010 |
Why?
|
| Albumins | 1 | 2002 | 72 | 0.010 |
Why?
|
| Endocardium | 1 | 2002 | 101 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2002 | 143 | 0.010 |
Why?
|
| Observer Variation | 1 | 2002 | 330 | 0.010 |
Why?
|
| Fluorocarbons | 1 | 2002 | 82 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2002 | 503 | 0.010 |
Why?
|
| Contrast Media | 1 | 2002 | 594 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2003 | 1615 | 0.010 |
Why?
|